These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 22041304)

  • 1. The influence of the stigma of obesity on H1N1 influenza vaccine sequencing in Canada in 2009.
    Kaposy C
    Vaccine; 2011 Dec; 29(52):9607-10. PubMed ID: 22041304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of the pandemic H1N1 influenza vaccines against laboratory-confirmed H1N1 infections: population-based case-control study.
    Mahmud S; Hammond G; Elliott L; Hilderman T; Kurbis C; Caetano P; Van Caeseele P; Kettner J; Dawood M
    Vaccine; 2011 Oct; 29(45):7975-81. PubMed ID: 21884747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccines against influenza A (H1N1) pandemic.
    Valdespino-Gomez JL; Garcia-Garcia L; de León-Rosales SP
    Arch Med Res; 2009 Nov; 40(8):693-704. PubMed ID: 20304259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population and risk group uptake of H1N1 influenza vaccine in mainland France 2009-2010: results of a national vaccination campaign.
    Bone A; Guthmann JP; Nicolau J; Lévy-Bruhl D
    Vaccine; 2010 Nov; 28(51):8157-61. PubMed ID: 20937310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of vaccine against pandemic influenza A/H1N1 among people with underlying chronic diseases: cohort study, Denmark, 2009-10.
    Emborg HD; Krause TG; Hviid A; Simonsen J; Mølbak K
    BMJ; 2011 Jan; 344():d7901. PubMed ID: 22277542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coverage and predictors of vaccination against 2009 pandemic H1N1 influenza in Madrid, Spain.
    Rodríguez-Rieiro C; Esteban-Vasallo MD; Domínguez-Berjón MF; Astray-Mochales J; Iniesta-Fornies D; Barranco-Ordoñez D; Cameno-Heras M; Jiménez-García R
    Vaccine; 2011 Feb; 29(6):1332-8. PubMed ID: 21182996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central European Vaccination Advisory Group (CEVAG) guidance statement on recommendations for 2009 pandemic influenza A(H1N1) vaccination.
    Chlibek R; Anca I; André F; Bakir M; Ivaskeviciene I; Mangarov A; Mészner Z; Perenovska P; Prymula R; Richter D; Salman N; Simurka P; Tamm E; Toplak N; Usonis V
    Vaccine; 2010 May; 28(22):3758-66. PubMed ID: 20380902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intent to receive influenza A (H1N1) 2009 monovalent and seasonal influenza vaccines - two counties, North Carolina, August 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Dec; 58(50):1401-5. PubMed ID: 20032923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of the monovalent influenza A(H1N1)2009 vaccine in Navarre, Spain, 2009-2010: cohort and case-control study.
    Castilla J; Morán J; Martínez-Artola V; Fernández-Alonso M; Guevara M; Cenoz MG; Reina G; Alvarez N; Arriazu M; Elía F; Salcedo E; Barricarte A;
    Vaccine; 2011 Aug; 29(35):5919-24. PubMed ID: 21723358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Summary recommendations by the Advisory Committee on Immunization Practices (ACIP) for the use of H1N1 influenza vaccine for the 2009-2010 vaccination season.
    Litchfield SM
    AAOHN J; 2009 Sep; 57(9):354. PubMed ID: 19842610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on influenza A (H1N1) 2009 monovalent vaccines.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Oct; 58(39):1100-1. PubMed ID: 19816398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interim results: influenza A (H1N1) 2009 monovalent vaccination coverage --- United States, October-December 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Jan; 59(2):44-8. PubMed ID: 20094027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2009-2010 novel influenza A (H1N1) vaccination coverage in the Republic of Korea.
    Lee YK; Kwon Y; Kim DW; Song KM; Cho H; Kim CH; Go UY; Bae GR; Lee JK
    Am J Infect Control; 2012 Jun; 40(5):481-3. PubMed ID: 21868134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seasonal influenza vaccination coverage in France during two influenza seasons (2007 and 2008) and during a context of pandemic influenza A(H1N1) in 2009.
    Tuppin P; Samson S; Weill A; Ricordeau P; Allemand H
    Vaccine; 2011 Jun; 29(28):4632-7. PubMed ID: 21550376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acceptance of a vaccine against pandemic influenza A (H1N1) virus amongst healthcare workers in Beijing, China.
    Seale H; Kaur R; Wang Q; Yang P; Zhang Y; Wang X; Li X; Zhang H; Zhang Z; MacIntyre CR
    Vaccine; 2011 Feb; 29(8):1605-10. PubMed ID: 21211593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors influencing uptake of influenza A (H1N1) vaccine amongst healthcare workers in a regional pediatric centre: lessons for improving vaccination rates.
    Chen SC; Hawkins G; Aspinall E; Patel N
    Vaccine; 2012 Jan; 30(2):493-7. PubMed ID: 21527302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
    Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007.
    Skowronski DM; De Serres G; Dickinson J; Petric M; Mak A; Fonseca K; Kwindt TL; Chan T; Bastien N; Charest H; Li Y
    J Infect Dis; 2009 Jan; 199(2):168-79. PubMed ID: 19086914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between intention of novel influenza A (H1N1) vaccination and vaccination coverage rate.
    Kwon Y; Cho HY; Lee YK; Bae GR; Lee SG
    Vaccine; 2010 Dec; 29(2):161-5. PubMed ID: 21055495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of an adjuvanted monovalent vaccine against the 2009 pandemic strain of influenza A(H1N1)v, in Stockholm County, Sweden.
    Ortqvist A; Berggren I; Insulander M; de Jong B; Svenungsson B
    Clin Infect Dis; 2011 May; 52(10):1203-11. PubMed ID: 21507917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.